Nuvectis Pharma, Inc.NVCTNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+16.2%
5Y CAGR+293.4%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+16.2%/yr
Annual compound
5Y CAGR
+293.4%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
942.1x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $9.42M | +36.0% |
| 2024 | $6.93M | -7.8% |
| 2023 | $7.52M | +25.1% |
| 2022 | $6.01M | +79.4% |
| 2021 | $3.35M | +33390.0% |
| 2020 | $10000.00 | - |